GKOS
Glaukos Corp · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website glaukos.com
- Employees(FY) 783
- ISIN US3773221029
Performance
+2.02%
1W
+13.24%
1M
+18.53%
3M
+69.59%
6M
+38.12%
YTD
+84.0%
1Y
Profile
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, an implantable device intended to reduce the intraocular pressure of the eye; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo California.
Investment Analysis Report: GKOS
Overview
In this investment analysis report, we will delve into the financial statements of GKOS, a company operating in the Health Technology sector with a focus on Medical Specialties. We will analyze the company's valuation, financial health, earnings and revenue growth, profitability, operating margin, operat...
Technical Analysis of GKOS 2024-05-10
Overview:
In analyzing the technical indicators for GKOS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Indicators:
- Moving Averages (MA): The 5-day MA has been consistently above the 10-day SMA, indi...
Recent News & Updates
- 2024-05-14 16:47
- 2024-05-14 12:20
- 2024-05-14 00:20
- 2024-05-08 06:02
- 2024-05-02 12:01
- 2024-05-02 11:59
- 2024-05-02 09:14
- 2024-05-02 07:12
Q1 2024 Glaukos Corp Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-02 03:38
- 2024-05-01 21:14
- 2024-05-01 17:50
- 2024-05-01 17:35
- 2024-05-01 16:50
Glaukos: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-01 16:05
Glaukos Announces First Quarter 2024 Financial Results(Business Wire)
- 2024-05-01 11:53
- 2024-05-01 04:05
Glaukos Announces First Quarter 2024 Financial Results(Businesswire)
- 2024-04-30 10:20
- 2024-04-23 20:00
GKOS: Raising target price to $84.00(Argus Research)
- 2024-04-16 16:05
- 2024-04-16 04:05
- 2024-04-15 08:19
- 2024-04-14 20:19
- 2024-04-12 09:22
- 2024-04-11 21:22
- 2024-04-11 10:47
Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)?(Simply Wall St.)
- 2024-04-10 07:00
- 2024-04-09 19:00
- 2024-04-08 10:41
- 2024-04-07 22:41
- 2024-04-04 12:02
Page 1 of 6
previousnext